ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,778.15
-1.22%
US Tech 100
19,968.00
0.74%
Dow Jones
42,520.99
-1.55%
Brent Oil
70.03
-1.41%
Bitcoin
89,943.64
3.11%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Atossa Therapeutics Inc (ATOS) Quote

Atossa Therapeutics Inc

Atossa Therapeutics Inc (ATOS)

NASDAQ
0.7324
-0.0086
(-1.16%)
Closed March 04 4:00PM
Delayed by 15 minutes
0.7324
0.00
( 0.00% )
Pre Market: 4:00AM
Delayed by 15 minutes
Advanced chart

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.7324
Bid
0.705
Ask
0.807
Volume
-
0.00 Day's Range 0.00
0.7064 52 Week Range 2.31
Market Cap
92.137M
Previous Close
0.7324
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
787,816
Shares Outstanding
125,801,254
Dividend Yield
-
PE Ratio
-3.05
Earnings Per Share (EPS)
-0.24
Revenue
-
Net Profit
-30.09M

About Atossa Therapeutics Inc

Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.atossatherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Atossa Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATOS. The last closing price for Atossa Therapeutics was $0.73. Over the last year, Atossa Therapeutics shares have traded in a share price range of $ 0.7064 to $ 2.31.

Atossa Therapeutics currently has 125,801,254 shares outstanding. The market capitalization of Atossa Therapeutics is $92.14 million. Atossa Therapeutics has a price to earnings ratio (PE ratio) of -3.05.

Ask ADVFN Intelligence (AI)

ATOS Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 24 2025
ATOS (-1.16%)

Form 8-K - Current report
Edgar (US Regulatory)
February 04 2025
ATOS (-1.16%)

Form 8-K - Current report
Edgar (US Regulatory)
December 10 2024
ATOS (-1.16%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0276-3.631578947370.760.790.70644810020.74998283CS
4-0.1218-14.25895574810.85420.88720.70645647540.79342805CS
12-0.5626-43.4440154441.2951.29820.70647878160.92144CS
26-0.6086-45.38404175991.3411.660.70646850481.14736787CS
52-0.2776-27.48514851491.012.310.706410958121.38764884CS
156-0.4776-39.47107438021.212.310.58686781.1627658CS
260-0.4776-39.47107438021.219.80.536228713.11468881CS

ATOS - Frequently Asked Questions (FAQ)

What is the current Atossa Therapeutics share price?
The current share price of Atossa Therapeutics is $ 0.7324
How many Atossa Therapeutics shares are in issue?
Atossa Therapeutics has 125,801,254 shares in issue
What is the market cap of Atossa Therapeutics?
The market capitalisation of Atossa Therapeutics is USD 92.14M
What is the 1 year trading range for Atossa Therapeutics share price?
Atossa Therapeutics has traded in the range of $ 0.7064 to $ 2.31 during the past year
What is the PE ratio of Atossa Therapeutics?
The price to earnings ratio of Atossa Therapeutics is -3.05
What is the reporting currency for Atossa Therapeutics?
Atossa Therapeutics reports financial results in USD
What is the latest annual profit for Atossa Therapeutics?
The latest annual profit of Atossa Therapeutics is USD -30.09M
What is the registered address of Atossa Therapeutics?
The registered address for Atossa Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Atossa Therapeutics website address?
The website address for Atossa Therapeutics is www.atossatherapeutics.com
Which industry sector does Atossa Therapeutics operate in?
Atossa Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ARBBARB IOT Group Ltd
$ 0.9366
(80.12%)
8.28M
GTIGraphjet Technology
$ 0.1849
(33.99%)
22.64M
AGHAureus Greenway Holdings Inc
$ 1.01
(31.17%)
6.65M
BHFBrighthouse Financial Inc
$ 69.99
(27.35%)
13
NVNINVNI Group Ltd
$ 0.3289
(25.30%)
30.04M
RETOReTo Eco Solutions Inc
$ 0.6257
(-29.30%)
99.9k
SYRESpyre Therapeutics Inc
$ 13.13
(-27.94%)
22
OMEROmeros Corporation
$ 6.01
(-24.69%)
8
ARHSArhaus Inc
$ 7.01
(-24.30%)
84
GHRSGH Research PLC
$ 7.21
(-23.22%)
3
NVNINVNI Group Ltd
$ 0.3289
(25.30%)
30.04M
GTIGraphjet Technology
$ 0.1849
(33.99%)
22.64M
CGBSCrown LNG Holdings Ltd
$ 0.2286
(-3.42%)
8.54M
ARBBARB IOT Group Ltd
$ 0.9366
(80.12%)
8.28M
BTOGBit Origin Ltd
$ 0.4135
(15.50%)
7.68M

ATOS Financials

Financials

ATOS Discussion

View Posts
eb0783 eb0783 1 month ago
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025.

https://investors.atossatherapeutics.com/news-releases/news-release-details/atossa-therapeutics-issues-letter-shareholders-highlighting-2024
👍️0
glenn1919 glenn1919 1 month ago
ATOS.........................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
XenaLives XenaLives 6 months ago
Why on earth did it take me so long to find this?



Following...

https://x.com/stevenquay
👍️0
XenaLives XenaLives 6 months ago
I think I'm in love... LOL!!!



Historical perspective:

👍️0
XenaLives XenaLives 6 months ago
More interesting...

https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
XenaLives XenaLives 6 months ago
ATOS chart...

👍️0
XenaLives XenaLives 6 months ago
Interesting .. also from Google...

A response to this query...

what is unique about atossa therapeutics inc

Response...

Is Atossa Therapeutics a good buy?
Why is Atossa stock dropping?
Who owns Atossa Therapeutics?
What is the target price for Atossa Genetics?
Stock Price Target ATOS
High $6.25
Median $6.00
Low $4.00
Average $5.42
Current Price $1.39

ATOS | Atossa Therapeutics Inc. Analyst Estimates & Rating - WSJ

WSJ
https://www.wsj.com › quotes › ATOS › research-ratings
Search for: What is the target price for Atossa Genetics?
What is the stock price forecast for Atossa Therapeutics in 2025?
What does Atossa Therapeutics do?


👍️0
XenaLives XenaLives 6 months ago
From Google Generative AI:


Atossa Therapeutics is a clinical-stage biopharmaceutical company that develops innovative medicines for oncology, with a focus on breast cancer and other breast conditions. Some unique aspects of Atossa Therapeutics include:
Patented (Z)-endoxifen
Atossa has patented the chemical process and composition of matter for (Z)-endoxifen, as well as a patented oral enteric capsule formulation.
Phase 2 I-SPY 2 Clinical Trial
Atossa is fully enrolling this trial, which is evaluating (Z)-endoxifen as a neoadjuvant treatment for patients with newly diagnosed estrogen receptor-positive breast cancer.
Phase 2 trials
Atossa is currently studying (Z)-endoxifen in four Phase 2 trials, including one in healthy women with measurable breast density, one in women diagnosed with ductal carcinoma in situ, and two other studies.
U.S. patents
Atossa's (Z)-endoxifen is protected by three issued U.S. patents and numerous pending patent applications.
👍️0
XenaLives XenaLives 6 months ago
Intriguing science...
👍️0
XenaLives XenaLives 6 months ago

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-00701&r=1
👍️0
XenaLives XenaLives 6 months ago
Link to Atossa pipeline...
https://atossatherapeutics.com/product-pipeline/
👍️0
XenaLives XenaLives 6 months ago
Following - some valid science is going on here...
👍️0
glenn1919 glenn1919 7 months ago
ATOS....................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 8 months ago
ATOS.........................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 8 months ago
ATOS...............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️ 1
Joeyohso Joeyohso 11 months ago
Also no debt and 90m+ in cash. That is unheard of for a research pharma company. They also are extending the employee stock purchase program for all of 2024. This stock is a gem
👍️0
ShadowDiviner72 ShadowDiviner72 11 months ago
New PR, and data release shows that Endoxifen does not only stop the tumor from growing...

It even shows that it eliminates the tumor !!!!!! They cured a patient from breast cancer by taking a simple pill during 6 months!

INCREDIBLE
👍️0
glenn1919 glenn1919 11 months ago
ATOS...........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
Joeyohso Joeyohso 11 months ago
Why the dump today? I was able to grab some at 1.65
👍️0
Monksdream Monksdream 11 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 11 months ago
ATOS new 52 hi
👍️0
Monksdream Monksdream 11 months ago
ATOS 10Q due 4/5
👍️0
Monksdream Monksdream 11 months ago
ATOS new 52 hi
👍️0
glenn1919 glenn1919 11 months ago
ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 11 months ago
ATOS..LEVEL 2 LOOKING VERY NICE IN PRE
👍️0
TrendTrade2016 TrendTrade2016 12 months ago
ATOS...GET READY TO RUMBLE...WE ARE LOCKED IN AND LOADED TO 1.73
👍️0
glenn1919 glenn1919 12 months ago
ATOS.............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 12 months ago
ATOS.........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
ATOS................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
👍️0
Birdbrain Ideas Birdbrain Ideas 2 years ago
There hasn't been a post on this board in six weeks. If these Stage 2 trials turn out well, this board will light up along with the share price.
👍️0
Laster Laster 2 years ago
I loved that wall at $1.04 yesterday. It was calling my name. I was too slow.
Then it was taken out. I wasn’t too upset because….
I was lucky enough for another wall at $1.05 that I helped take out. Then boom.
Chart looked good. News good. Repurchase plan news excellent.
What’s not to like.
Hope to see if move back above $2.
Good luck.
👍️0
tw0122 tw0122 2 years ago
Looking good. Hidden gem not any longer
👍️0
killrEngineer killrEngineer 2 years ago
Wow. No comments?
10 million share repurchase announcement yesterday and study enrollment announcement today.
👍️0
DrJinx DrJinx 2 years ago
This aged like milk. How's that priming for a big run up working out for you? Maybe someday people will realize the company is smoke and mirrors. Keep in mind your CEO is old as F, he dies... this thing tanks even harder.
👍️0
Engle1488 Engle1488 3 years ago
We are primed for a big run up people. In at 1.04
👍️0
Agreed Agreed 3 years ago
The market cap is less than their holdings in cash...clearly undervalued.
👍️0
Agreed Agreed 3 years ago
Insider buying by CEO and CFO, new patent protections...looking promising.
👍️0
DollarSquad DollarSquad 3 years ago
Yes. You likely lost a lot of money. This investment is worthless. RMSL
👍️0
4MVault 4MVault 3 years ago
Did something just happen?
👍️0
slugo1 slugo1 3 years ago
Looking for bottom here
👍️0
ttottip ttottip 3 years ago
Yes, very soon. This will reverse the trend.
👍️0
slugo1 slugo1 3 years ago
Soon
👍️0
ttottip ttottip 3 years ago
Soon the 2.5's , 2.6's .....
👍️0
slugo1 slugo1 3 years ago
Yes
👍️0
ttottip ttottip 3 years ago
The 2.6's on the horizon.
👍️0
slugo1 slugo1 3 years ago
That's one of the things I like about them Also there should be some updates coming
👍️0
ttottip ttottip 3 years ago
140 millions of dollars cash? ATOS can do great things with this money.
👍️0
slugo1 slugo1 3 years ago
Nice buy worth alot when this hits $10.00
👍️0

Your Recent History

NASDAQ
ATOS
Atossa Therapeutics
USOTC
SOTGY
Sunny Optical Technology (PK)
TSXV
AMY
Recylico Battery Materials
NASDAQ
AMZN
Amazon.com
NASDAQ
PANL
Pangaea Logistics Soluti...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads